Advertisement
News
Subscribe to MDT Magazine News

TSX-listed corporate dividends and distributions declared April 25, 2011(2)

April 25, 2011 11:46 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on April 25, 2011.Senior Gold Producers Income Corp. Cl 'a' (TSX:GPC): $0.0625. Payable Jul 15. Record Jun 30.Acuity Focused Total Return Trust Units (TSX:AFU.UN): $0.03. Payable Jun...

TSX-listed corporate dividends and distributions declared April 25, 2011

April 25, 2011 11:45 am | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on April 25, 2011.Senior Gold Producers Income Corp. Cl 'a' (TSX:GPC): $0.0625. Payable Jul 15. Record Jun 30.Acuity Focused Total Return Trust Units (TSX:AFU.UN): $0.03. Payable Jun...

New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics

April 25, 2011 10:39 am | by Bio-Medicine.Org | Comments

BRYAN/COLLEGE STATION, Texas, April 25, 2011 /- Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of...

TOPICS:
Advertisement

Meaningful Use Outcomes will Change Reporting

April 25, 2011 10:35 am | by Diagnostic Imaging | Comments

The usual EHR approach won't suffice in the future. You need to be able to get orders electronically and be more responsible to patients with your reporting.

TOPICS:

Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials

April 25, 2011 10:34 am | by Bio-Medicine.Org | Comments

NORTH KINGSTOWN, R.I., April 25, 2011 /- On Wednesday, April 27 at 11 a.m., Dominion Diagnostics will host Rhode Island Congressman James R. Langevin, Governor Lincoln Chafee, Lieutenant Governor Elizabeth H. Roberts, and their staffs for a laboratory tour and luncheon at its headquarters...

TOPICS:

AACR Opens Nominations for Award Funded by Susan G. Komen for the Cure®

April 25, 2011 10:33 am | by AACR | Comments

Tweet PHILADELPHIA - The American Association for Cancer Research announces a call for nominations for the 2011 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure®. The award recognizes a scientist who is no more than 50 years old and who...

TOPICS:

PatientsLikeMe uses social network for ALS study

April 25, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

PatientsLikeMe, a social network that connects patients with various chronic conditions, has published a study in the journal Nature Biotechnology arguing that lithium carbonate does not slow the progression of ALS, also known as Lou Gehrig's disease.

Boston Scientific gets FDA OK for ION stent system

April 25, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Continuing a spring fling of stent approvals, Boston Scientific Corp. today announced that it had won approval from the FDA for its ION drug-eluting coronary stent.

Advertisement

Acetylon Pharmaceuticals expands advisory board

April 25, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Acetylon Pharmaceuticals Inc., a Boston biotech working on small molecule drugs to treat cancer and other diseases, today announced two new members of its scientific advisory board – Wayne William Hancock and Tso-Pang Yao.

Nano Terra licenses nanotech, ex-Surface Logix platform

April 25, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Nano Terra Inc., a Brighton nanotechnology development firm, is giving an exclusive worldwide license to three disease-oriented product candidates and rights to its Pharmacomer drug discovery platform to New York City biotechnology firm Kadmon Pharmaceuticals LLC.

Dealing With Stress in Radiology

April 25, 2011 9:35 am | by Diagnostic Imaging | Comments

Your least-favorite tech makes a rookie blunder and screws up a study, perhaps, or PACS fails just as you are hit by a quartet of STATs. What do you do with your aggravation?

TOPICS:

Consumer Information on: MEL 80? Excimer Laser System - P060004S001

April 25, 2011 8:31 am | by U.S. Food & Drug Administration | Comments

The Carl Zeiss Meditec MEL 80? Excimer Laser System is a refractive excimer laser designed for a particular type of surgery called LASIK2 (laser-assisted in situ keratomileusis) to change how the eye bends light (refractive surgery). The laser system...

TOPICS:

Summary Information for: MEL 80? Excimer Laser System

April 25, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for MEL 80? Excimer Laser System (P060004S001).

TOPICS:

Boston Scientific gets FDA for ION stent system

April 25, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Continuing a spring fling of stent approvals, Boston Scientific Corp. today announced that it had won approval from the FDA for its ION drug-eluting coronary stent.

Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer

April 25, 2011 7:36 am | by Bio-Medicine.Org | Comments

NEW YORK, April 25, 2011 /- Accuracy in radiation therapy demands careful targeting and patient positioning – precision measured in millimeters. The Farber Center for Radiation Oncology , the first and only freestanding cancer center of its kind in Manhattan, is among the first...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading